Severe mononucleosis syndrome with cholestasic hepatitisin a non-immunocompromised patient: case report

Authors

  • Patricia E. Jaramillo-Arbeláez University of Antioquia
  • Francisco Cuéllar Ambrosi University of Antioquia

DOI:

https://doi.org/10.17533/udea.hm.5227

Keywords:

burkitt lymphoma, cholestasic hepatitis, Epstein Barr virus, mononucleosis syndrome, reactive lymphocytes

Abstract

Mononucleosis syndrome is frequently associated with the Epstein Barr virus (EBV), which is related with Burkitt lymphoma, non-differentiated nose-throat carcinoma and lympho-proliferative illness. There is a serology association between the infection and Hodgkin’s disease and, in addition, the pathogenesis of the uterus neck cancer and EBV relation is studied. The reported clinic case patient presented a meaningful increase in reactive lymphocytes with abnormal morphological characteristics and important clinical complications such as multiple adenopathies, hepatomegaly, splenomegaly, hypertransaminases and hyperbilirubinemia, which excluded various differential diagnoses. Finally, according to the clinical history, the diagnostic results and the evolution of the patient, it is concluded that the diagnosis is a mononucleosis syndrome in a patient without immune deficiency and with cholestasic hepatitis due to an infection with EBV. The immunohistochemical studies of the ganglion biopsy allowed the exclusion of a diagnosis of lymphoma; consequently, the activated cells are not neoplastic. 
|Abstract
= 258 veces | PDF (ESPAÑOL (ESPAÑA))
= 92 veces|

Downloads

Download data is not yet available.

Author Biographies

Patricia E. Jaramillo-Arbeláez, University of Antioquia

Bacteriologist and Clinical Laboratorian. Specialist in Hematology and Blood Bank. Master's candidate in Microbiology. Professor of Microbiology, University of Antioquia. Bacteriologist of the University IPS - León XIII Clinic, Colombia.

Francisco Cuéllar Ambrosi, University of Antioquia

Physician and Surgeon. Internal Medicine specialist. Subspecialist in Hematology. Studies in Transplant Medicine. Head of the Department of Hematology, University of Antioquia, Colombia. 

References

Barreales M, Pérez-Carreras M, Meizoso T, Garrido M, Masedo A, Colina F, et al. Epstein-Barr virus infection and acute cholestatic hepatitis. An Med Interna. 2006 Oct; 23(10): 483-6.

Doğan I, Ergün M, Cindoruk M, Unal S. Acute hepatitis induced by Epstein-Barr virus infection: a case report. Turk J Gastroenterol. 2007 Jun; 18(2): 119-21.

Massei F, Palla G, Ughi C, Macchia P, Maggiore G. Ch-lestasis as a presenting feature of acute Epstein-Barr virus infection. Pediatr Infect Dis J. 2001 Jul; 20(7): 721-2.

Park M, Chung I, Park Y, Chung Y, Lee H, Cho H, et al.A case of cholestatic hepatitis induced by epsteinbarr virus infection. Korean J Hepatol. 2006 Jun; 12(2): 237-42.

Aksoy S, Kilickap S, Hayran M, Harputluoglu H, Koca E, Dede D, et al. Platelet size has diagnostic predictive value for bone marrow metastasis in patients with solid tumors. Int J Lab Hematol. 2008 Jun; 30(3): 214-9.

Published

2010-05-06

How to Cite

Jaramillo-Arbeláez, P. E. ., & Cuéllar Ambrosi, F. (2010). Severe mononucleosis syndrome with cholestasic hepatitisin a non-immunocompromised patient: case report. Hechos Microbiológicos, 1(1), 87–90. https://doi.org/10.17533/udea.hm.5227

Issue

Section

Presentación de casos